An Introduction to Real-world Data and Tips for Analysing It

被引:1
|
作者
Imai, Shinobu [1 ]
机构
[1] Tokyo Univ Pharm & Life Sci, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2021年 / 141卷 / 02期
关键词
medical big data; real-world data; observational study; sample size; validation study;
D O I
10.1248/yakushi.20-00196-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Medical big data, also referred to as 'real-world data' (RWD) is defined as "data related to patient health status and/or health care delivery collected routinely from a variety of sources". This includes data from disease and drug registries, electronic health records, claims and billing data and census data collected from clinicians, hospitals, and payers. Observational studies using RWD collected during general clinical practice are considered complementary to randomized control trials. However, since this design does not allow the random assignment of patients, causal inference analyses are required. Researchers should study the protocol properly before considering the combination of study design, the characteristics of data source, calculation of the appropriate sample size and the validity of outcomes. Data definition using data code should also be considered. Furthermore, the reliability of the source studies must be considered and discussed when the article is written. This review aims to outline the methods for performing reliable observational studies using RWD.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 50 条
  • [21] Flexible density peak clustering for real-world data
    Hou, Jian
    Lin, Houshen
    Yuan, Huaqiang
    Pelillo, Marcello
    PATTERN RECOGNITION, 2024, 156
  • [22] The use of real-world data/evidence in regulatory submissions
    Song, Fuyu
    Zang, Chenxuan
    Ma, Xinyi
    Hu, Sifan
    Sun, Qiqing
    Chow, Shein-Chung
    Sun, Hongqiang
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [23] Adding value to real-world data: the role of biomarkers
    Plant, Darren
    Barton, Anne
    RHEUMATOLOGY, 2020, 59 (01) : 31 - 38
  • [24] New oral anticoagulant drugs: real-world data
    Iqbal, Omer
    PERSONALIZED MEDICINE, 2013, 10 (05) : 419 - 422
  • [25] An Overview of Real-World Data Infrastructure for Cancer Research
    Price, G.
    Peek, N.
    Eleftheriou, I.
    Spencer, K.
    Paley, L.
    Hogenboom, J.
    van Soest, J.
    Dekker, A.
    van Herk, M.
    Faivre-Finn, C.
    CLINICAL ONCOLOGY, 2025, 38
  • [26] Current status and challenges in establishing reference intervals based on real-world data
    Ma, Sijia
    Yu, Juntong
    Qin, Xiaosong
    Liu, Jianhua
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2023, 60 (06) : 427 - 441
  • [27] Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
    Hong, Chun-Ming
    Liu, Chen-Hua
    Su, Tung-Hung
    Yang, Hung-Chih
    Chen, Pei-Jer
    Chen, Yu-Wen
    Kao, Jia-Horng
    Liu, Chun-Jen
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (04) : 569 - 577
  • [28] Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulation
    Breckenridge, Alasdair M.
    Breckenridge, Ross A.
    Peck, Carl C.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (09) : 1874 - 1877
  • [29] Old dog with new tricks: An introduction to real-world evidence for pharmacists
    Rahmatian, Donna
    Tadrous, Mina
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (24) : 2277 - 2280
  • [30] Inflammation-based prognostic markers of metastatic pancreatic cancer using real-world data in Japan: The Tokushukai REAl-world Data (TREAD) project
    Shimoyama, Rai
    Imamura, Yoshinori
    Uryu, Kiyoaki
    Mase, Takahiro
    Shiragami, Megumi
    Fujimura, Yoshiaki
    Hayashi, Maki
    Ohtaki, Megu
    Ohtani, Keiko
    Shinozaki, Nobuaki
    Minami, Hironobu
    ONCOLOGY LETTERS, 2024, 27 (03)